Hercules Capital Inc.

www.htgc.com

Foreign Financial Services Company
Public Company

(NYSE: HTGC)

Tech Verticals Preferences

AgriTech, Biopharmaceuticals, Biotechnology, Cyber Security, Data Analytics, DevOps, Digital Health, Digital Media, Drug Discovery, e-Commerce, EdTech, E-Learning, Energy Tech, Enterprise Applications, Entertainment, Environment, FinTech, Healthtech, Industry 4.0, IoT, Materials, Medical Devices, MedTech, Mobile Security, Network Security, Pharmaceuticals, SaaS, Security, Smart Grid, Software Technologies, Solar Tech, Therapeutics, WaterTech, Wind Energy

General Data

Established	2003
Current Active Portfolio Companies:	8

DESCRIPTION

Hercules Capital, Inc. (NYSE: HTGC) is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies in a broad variety of technology and life sciences industries. Since inception (December 2003), Hercules has committed over $23 billion to over 690 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing.

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Law Firm

REMARKS

Date	Remark
	HTGC is affiliated with Israeli Investment Bank, Market Bridges, which serves as exclusive representative in Israel and acts as deal-finder and exclusive contact channel.

CONTACT INFO

Expand / Collapse All

Main Address: San Mateo, United States

Address	1 N B St. Suite 2000
City	San Mateo
State/Province	CA
Country	United States
Zip	94401

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Boston, United States

Address	31 St. James Avenue, Suite 1005
City	Boston
State/Province	MA
Country	United States
Zip	02116

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Roy Liu	Managing Director
Ms. Ella-Tamar Adhanan	Managing Director - Venture & Technology Lending	SVB Financial Group (Director, Head of Israel and India)

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Jun. 09, 2005	IPO	NYSE	abCDe	abCDe

Investment Data

Capital Remarks

Hercules is widely recognized as the largest non-bank source of venture financing in the market, with over $5.3 billion in assets under management and a market capitalization of over $3.0 billion.

Preferences

Maximum investments	$300m
Minimum investments	$5m
Type of Financing	Bridge Loans,Equity,Loans - Straight,Venture Lending
Stage Preferences	Initial Revenues,R&D,Revenue Growth,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Enterprise Software & Infrastructure

74%

Medical Devices

13%

Biomed

13%

	PORTFOLIO COMPANIES

Current Portfolio Companies (8)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Armis

Ent. SW

Debt Financing

01/03/2024

$150m

Earnix

Ent. SW

Debt Financing

06/06/2024

$19m

Hypercore

Ent. SW

First Round

23/02/2026

N/A

$13.5m

InspireMD

Venture Lending

24/10/2013

$10m

Kamada

Biomed

Venture Lending

24/01/2008

$20m

05/2009: Exchanged some of the debt to equity. 10/2009: Kamada returned Hercules $20m.

Semperis

Ent. SW

Fourth Round

20/06/2024

$23m

$125m

Sisense

Ent. SW

Debt Financing

01/06/2023

N/A

$33m

Tipalti

Ent. SW

Debt Financing	24/09/2025	$200m	$200m
Debt Financing	15/05/2023	N/A	$150m

Exits (9)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	18/02/2026	abCDe
abC Defghij	Acquired	15/07/2020	abCDe	Advent has partnered with Crosspoint Capital Partners, a private equity investment firm focused on cybersecurity and privacy industries, as an advisor on this transaction.
abC Defghij	IPO	27/10/2017	abCDe	Including Green Shoe Option ($8m). 08/2020: Delisted following acquisition by Advent.
abC Defghij	Acquired	01/10/2007	abCDe	In cash.
abC Defghij	Acquired	26/01/2022	abCDe
abC Defghij	Acquired	24/10/2008	abCDe	Through Ethicon division; in cash
abC Defghij	IPO	21/04/2006	abCDe	Including Green Shoe options.
abC Defghij	Acquired	17/09/2017	abCDe	Acquired PeerApp via its subsidiary Skyvera Solutions Inc.
abC Defghij	Acquired	01/07/2009	abCDe

Historic Portfolio (1)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Gelesis

Ceased to Operate

Biomed

Fifth Round

26/03/2015

N/A

$22m

Last Updated:	abCDe
IVC Number:	abCDe